Agent and method for treating cancer comprising strontium, amino acid(s) and mineral agent(s)

Details for Australian Patent Application No. 2004281559 (hide)

International Classifications

Event Publications

1 June 2006 PCT application entered the National Phase

PCT publication WO2005/037295 Priority application(s): WO2005/037295

25 March 2010 Assignment before Grant

Helsingfors Institution for Bioimmunterapi AB The application has been assigned to Oy Neurofood AB

1 April 2010 Application Accepted

Published as AU-B-2004281559

29 July 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.